Micronized cellular adipose matrix as a therapeutic injectable for diabetic ulcer
This Short Communication by Jingwei Feng et al., University of Tokyo Graduate School of Medicine, Japan, researches the potential of micronized cellular adipose matrix – a bioactive injectable consisting of functional ECM and resident cells such as ASCs – to accelerate healing in ischemic diabetic ulcers.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.